Therapeutic potential of stem cell in liver regeneration

被引：12

作者：

Li J. ^{[1
]}

Li M. ^{[1
]}

Niu B. ^{[1
]}

Gong J. ^{[1
]}

机构：

[1] Chongqing Key Laboratory of Hepatobiliary Surgery and Department of Hepatobiliary Surgery, Second Affiliated Hospital, Chongqing Medical University

来源：

Frontiers of Medicine | 2011年 / 5卷 / 1期

基金：

中国国家自然科学基金;

关键词：

Liver disease; Regenerative medicine; Stem cell;

D O I：

10.1007/s11684-011-0107-0

中图分类号：

学科分类号：

摘要：

Liver transplantation is the only life-saving procedure for patients with end-stage liver disease. However, its potential benefits are hampered by many disadvantages, such as the relative shortage of donors, operative risks, and high costs. These issues have prompted the search for new alternative therapies for irreversible liver disease. Stem cell therapy, with the ability for self-renewal and potential for multilineage differentiation, is a promising alternative approach. Several studies have demonstrated that transplantation of hepatic stem/ progenitor cells or hepatocyte-like cells derived from multipotent stem cells leads to donor cell-mediated repopulation of the liver and improved survival rates in experimental models of liver disease. However, a registered clinical application based on stem cell technology will take at least an additional 5 to 10 years because of some limitations; e.g. the lack of suitable cell sources and risk of teratoma formation. This review summarizes the general understanding of the therapeutic potentials of stem cells in liver disease, including the sources, mechanisms, and delivery methods of hepatic stem cells in liver regeneration, and discusses some challenges for their therapeutic application. © Higher Education Press and Springer-Verlag Berlin Heidelberg 2011.

引用

页码：26 / 32

页数：6

共 62 条

[1]

O'Leary J.G., Lepe R., Davis G.L., Indications for liver transplantation, Gastroenterology, 134, 6, pp. 1764-1776, (2008)

[2]

Kung J.W., Forbes S.J., Stem cells and liver repair, Curr Opin Biotechnol, 20, 5, pp. 568-574, (2009)

[3]

Ogawa S., Miyagawa S., Potentials of regenerative medicine for liver disease, Surg Today, 39, 12, pp. 1019-1025, (2009)

[4]

Ehnert S., Glanemann M., Schmitt A., Vogt S., Shanny N., Nussler N.C., Stockle U., Nussler A., The possible use of stem cells in regenerative medicine: Dream or reality?, Langenbecks Arch Surg, 394, 6, pp. 985-997, (2009)

[5]

Alison M.R., Islam S., Lim S., Stem cells in liver regeneration, fibrosis and cancer: The good, the bad and the ugly, J Pathol, 217, 2, pp. 282-298, (2009)

[6]

Fausto N., Campbell J.S., Riehle K.J., Liver regeneration, Hepatology, 43, SUPPL. 1, (2006)

[7]

Roskams T.A., Theise N.D., Balabaud C., Bhagat G., Bhathal P.S., Bioulac-Sage P., Brunt E.M., Crawford J.M., Crosby H.A., Desmet V., Finegold M.J., Geller S.A., Gouw A.S., Hytiroglou P., Knisely A.S., Kojiro M., Lefkowitch J.H., Nakanuma Y., Olynyk J.K., Park Y.N., Portmann B., Saxena R., Scheuer P.J., Strain A.J., Thung S.N., Wanless I.R., West A.B., Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers, Hepatology, 39, 6, pp. 1739-174

[8]

Dorrell C., Grompe M., Liver repair by intra-and extrahepatic progenitors, Stem Cell Rev, 1, 1, pp. 61-64, (2005)

[9]

Lee J.S., Heo J., Libbrecht L., Chu I.S., Kaposi-Novak P., Calvisi D.F., Mikaelyan A., Roberts L.R., Demetris A.J., Sun Z., Nevens F., Roskams T., Thorgeirsson S.S., A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells, Nat Med, 12, 4, pp. 410-416, (2006)

[10]

Tanaka M., Okabe M., Suzuki K., Kamiya Y., Tsukahara Y., Saito S., Miyajima A., Mouse hepatoblasts at distinct developmental stages are characterized by expression of EpCAM and DLK1: Drastic change of EpCAM expression during liver development, Mech Dev, 126, 8-9, pp. 665-676, (2009)

← 1 2 3 4 5 6 7 →